Colorado Moves to Allow Hallucinogen Ibogaine for Medical Use
Ibogaine, derived from the root of the iboga shrub native to Central Africa, has been shown in small studies to reduce opioid withdrawal symptoms and help treat traumatic brain injuries, though clinical evidence is still limited.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Gerard C. Murphy Gerry Murphy was born in Brooklyn, New York
Jul. 11—Gerard C. Murphy Gerry Murphy was born in Brooklyn, New York on May 14, 1947 and left this world on June 18, 2025 in Albuquerque, New Mexico. He graduated from Fordham College, Magna Cum Laude, with a B.A. in Mathematics, and also received an M.S. in Mathematics from Polytechnic Institute of New York where he completed all course work towards a Ph.D. He taught Math at the Hackley School in Tarry-town, New York from 1971 to 1990 where he became Chairman of the Department and was awarded the Wallace McLean Chair in Math and Science. He then taught Math at Albuquerque Academy from 1990 to 2011. He loved teaching, skiing, playing tennis, traveling, reading, taking photographs, music, and was a member of the Zen Buddhist community in New York. Gerry will always be remembered as smart and very funny. He will be greatly missed by his family and friends. He leaves behind his wife of 56 years, Doreen Mazza Murphy; his sister, Virginia Murphy of Durham, England and her family; and his brother-in-law, Tony Mazza and wife Mona Look-Mazza of Aspen, Colorado. He is the son of the late Francis Murphy and Dorothy Colvell Murphy and the nephew of the late Virginia Colvell, all of Brooklyn, New York. There will be a private graveside service at Gate of Heaven Cemetery in Hawthorne, New York.
Yahoo
38 minutes ago
- Yahoo
Why Clover Health (CLOV) Shares Are Trading Lower Today
Shares of health insurance company Clover Health (NASDAQ:CLOV) fell 4.8% in the afternoon session after a filing revealed that the company's CEO, Wai Conrad, sold a portion of his holdings. According to a regulatory filing on July 11, 2025, CEO Wai Conrad sold 15,203 shares of Class A Common Stock on July 8 for a total of approximately $49,561. The transactions were made at prices ranging from $3.25 to $3.27 per share. While the sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell a predetermined number of shares at a predetermined time, the news can still create unease among investors. Insider selling, even when planned, is often scrutinized by the market for any signals about a company's future prospects, contributing to negative pressure on the stock price. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Clover Health? Access our full analysis report here, it's free. Clover Health's shares are extremely volatile and have had 45 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Clover Health is down 7.2% since the beginning of the year, and at $2.91 per share, it is trading 39.7% below its 52-week high of $4.82 from January 2025. Investors who bought $1,000 worth of Clover Health's shares 5 years ago would now be looking at an investment worth $261.71. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Why Owens & Minor (OMI) Shares Are Sliding Today
Shares of medical supply and logistics company Owens & Minor (NYSE:OMI) fell 3% in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White House announced plans to impose a 35% tariff on Canadian imports, sparking renewed fears of a trade war. This news prompted a sell-off across major U.S. indexes, including the S&P 500 and the Dow Jones Industrial Average, as investors grew concerned about the potential economic impact of escalating protectionist policies. The healthcare sector is especially vulnerable to such tensions due to its deeply integrated supply chains with Canada for pharmaceuticals and medical devices, meaning increased costs and potential disruptions. Additionally, ongoing U.S. policy headwinds aimed at lowering drug prices and specific corporate challenges, like those faced by UnitedHealth Group, further compounded the sector's decline. As a result, the Health Care SPDR ETF (XLV) fell 1.0%, underperforming even as major indices pared some losses. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Owens & Minor? Access our full analysis report here, it's free. Owens & Minor's shares are extremely volatile and have had 44 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Owens & Minor is down 37.3% since the beginning of the year, and at $8.06 per share, it is trading 51.1% below its 52-week high of $16.48 from July 2024. Investors who bought $1,000 worth of Owens & Minor's shares 5 years ago would now be looking at an investment worth $1,095. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
